{"pmid":32257728,"pmcid":"PMC7123290","title":"Coronavirus Disease (COVID-19) and Pediatric Patients: A Review of Epidemiology, Symptomatology, Laboratory and Imaging Results to Guide the Development of a Management Algorithm.","text":["Coronavirus Disease (COVID-19) and Pediatric Patients: A Review of Epidemiology, Symptomatology, Laboratory and Imaging Results to Guide the Development of a Management Algorithm.","Coronavirus disease (COVID-19) has been declared a worldwide pandemic. Compared to adults, there has been a significantly smaller number of reported cases of COVID-19 in the pediatric population, although the incidence is increasing every day. This article looks to review specific epidemiological factors, symptomatology, laboratory and imaging workup, and other relevant metrics derived from the limited published literature that are specific to the pediatric population, to provide a review for the pediatric practitioner and guide, in part, the creation of a clinical algorithm for the management of COVID-19 in the pediatric population that can be utilized by pediatric institutions.","Cureus","Hasan, Ali","Mehmood, Noormah","Fergie, Jamie","32257728"],"abstract":["Coronavirus disease (COVID-19) has been declared a worldwide pandemic. Compared to adults, there has been a significantly smaller number of reported cases of COVID-19 in the pediatric population, although the incidence is increasing every day. This article looks to review specific epidemiological factors, symptomatology, laboratory and imaging workup, and other relevant metrics derived from the limited published literature that are specific to the pediatric population, to provide a review for the pediatric practitioner and guide, in part, the creation of a clinical algorithm for the management of COVID-19 in the pediatric population that can be utilized by pediatric institutions."],"journal":"Cureus","authors":["Hasan, Ali","Mehmood, Noormah","Fergie, Jamie"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32257728","week":"202015|Apr 06 - Apr 12","doi":"10.7759/cureus.7485","keywords":["coronavirus disease","covid-19"],"source":"PubMed","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1663450393498091520,"score":7.9164424,"similar":[{"pmid":32267047,"title":"Special considerations for the management of COVID-19 pediatric patients in the operating room and pediatric intensive care unit in a tertiary hospital in Singapore.","text":["Special considerations for the management of COVID-19 pediatric patients in the operating room and pediatric intensive care unit in a tertiary hospital in Singapore.","COVID-19 was first identified in Wuhan, China and is caused by the novel coronavirus SARS-CoV 2. It has now spread rapidly to over 190 countries and territories around the world and has been declared a global pandemic by the World Health Organization. The virus is spread through droplet transmission and currently has a mortality rate of over 4% globally. The pediatric population has been found to be less susceptible to the disease with the majority of children having milder symptoms and only one pediatric death being reported globally so far. Despite this, strategies need to be put in place to prevent further spread of the virus. We present a summary of the general measures implemented at a large adult and pediatric tertiary hospital in Singapore (National University Hospital) as well as the specific strategies in place for the operating room and pediatric intensive care unit.","Paediatr Anaesth","Thampi, Swapna","Yap, Andrea","Lijia, Fan","Ong, Jacqueline","32267047"],"abstract":["COVID-19 was first identified in Wuhan, China and is caused by the novel coronavirus SARS-CoV 2. It has now spread rapidly to over 190 countries and territories around the world and has been declared a global pandemic by the World Health Organization. The virus is spread through droplet transmission and currently has a mortality rate of over 4% globally. The pediatric population has been found to be less susceptible to the disease with the majority of children having milder symptoms and only one pediatric death being reported globally so far. Despite this, strategies need to be put in place to prevent further spread of the virus. We present a summary of the general measures implemented at a large adult and pediatric tertiary hospital in Singapore (National University Hospital) as well as the specific strategies in place for the operating room and pediatric intensive care unit."],"journal":"Paediatr Anaesth","authors":["Thampi, Swapna","Yap, Andrea","Lijia, Fan","Ong, Jacqueline"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267047","week":"202015|Apr 06 - Apr 12","doi":"10.1111/pan.13863","keywords":["COVID-19","General anesthesia","PICU","Pediatric","SARS-CoV 2"],"source":"PubMed","locations":["Singapore","Wuhan","China"],"countries":["Singapore","China"],"countries_codes":["SGP|Singapore","CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663609715772358658,"score":260.46985},{"pmid":32180140,"title":"Clinical features of pediatric patients with COVID-19: a report of two family cluster cases.","text":["Clinical features of pediatric patients with COVID-19: a report of two family cluster cases.","BACKGROUND: Coronovirus disease 2019 (COVID-19) has spread rapidly across the globe. People of all ages are susceptible to COVID-19. However, literature reports on pediatric patients are limited. METHODS: To improve the recognition of COVID-19 infection in children, we retrospectively reviewed two confirmed pediatric cases from two family clusters. Both clinical features and laboratory examination results of the children and their family members were described. RESULTS: The two confirmed children only presented with mild respiratory or gastrointestinal symptoms. Both of them had normal chest CT images. After general and symptomatic treatments, both children recovered quickly. Both families had travel histories to Hubei Province. CONCLUSIONS: Pediatric patients with COVID-19 are mostly owing to family cluster or with a close contact history. Infected children have relatively milder clinical symptoms than infected adults. We should attach importance to early recognition, early diagnosis, and early treatment of infected children.","World J Pediatr","Ji, Li-Na","Chao, Shuang","Wang, Yue-Jiao","Li, Xue-Jun","Mu, Xiang-Dong","Lin, Ming-Gui","Jiang, Rong-Meng","32180140"],"abstract":["BACKGROUND: Coronovirus disease 2019 (COVID-19) has spread rapidly across the globe. People of all ages are susceptible to COVID-19. However, literature reports on pediatric patients are limited. METHODS: To improve the recognition of COVID-19 infection in children, we retrospectively reviewed two confirmed pediatric cases from two family clusters. Both clinical features and laboratory examination results of the children and their family members were described. RESULTS: The two confirmed children only presented with mild respiratory or gastrointestinal symptoms. Both of them had normal chest CT images. After general and symptomatic treatments, both children recovered quickly. Both families had travel histories to Hubei Province. CONCLUSIONS: Pediatric patients with COVID-19 are mostly owing to family cluster or with a close contact history. Infected children have relatively milder clinical symptoms than infected adults. We should attach importance to early recognition, early diagnosis, and early treatment of infected children."],"journal":"World J Pediatr","authors":["Ji, Li-Na","Chao, Shuang","Wang, Yue-Jiao","Li, Xue-Jun","Mu, Xiang-Dong","Lin, Ming-Gui","Jiang, Rong-Meng"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32180140","week":"202012|Mar 16 - Mar 22","doi":"10.1007/s12519-020-00356-2","keywords":["COVID-19","Children","Coronavirus","Wuhan"],"source":"PubMed","locations":["Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1663352133856002050,"score":227.00655},{"pmid":32265372,"title":"Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature.","text":["Coronavirus Disease 2019 in Critically Ill Children: A Narrative Review of the Literature.","Coronavirus disease 2019 has spread around the world. In the 3 months since its emergence, we have learned a great deal about its clinical management and its relevance to the pediatric critical care provider. In this article, we review the available literature and provide valuable insight into the clinical management of this disease, as well as information on preparedness activities that every PICU should perform.","Pediatr Crit Care Med","Ong, Jacqueline S M","Tosoni, Alvise","Kim, YaeJean","Kissoon, Niranjan","Murthy, Srinivas","32265372"],"abstract":["Coronavirus disease 2019 has spread around the world. In the 3 months since its emergence, we have learned a great deal about its clinical management and its relevance to the pediatric critical care provider. In this article, we review the available literature and provide valuable insight into the clinical management of this disease, as well as information on preparedness activities that every PICU should perform."],"journal":"Pediatr Crit Care Med","authors":["Ong, Jacqueline S M","Tosoni, Alvise","Kim, YaeJean","Kissoon, Niranjan","Murthy, Srinivas"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32265372","week":"202015|Apr 06 - Apr 12","doi":"10.1097/PCC.0000000000002376","source":"PubMed","topics":["Diagnosis","Mechanism","Treatment","Prevention"],"weight":1,"_version_":1663609715815350273,"score":224.77357},{"pmid":32271728,"title":"Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.","text":["Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.","As of April 2, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in >890,000 cases and >45,000 deaths worldwide, including 239,279 cases and 5,443 deaths in the United States (1,2). In the United States, 22% of the population is made up of infants, children, and adolescents aged <18 years (children) (3). Data from China suggest that pediatric COVID-19 cases might be less severe than cases in adults and that children might experience different symptoms than do adults (4,5); however, disease characteristics among pediatric patients in the United States have not been described. Data from 149,760 laboratory-confirmed COVID-19 cases in the United States occurring during February 12-April 2, 2020 were analyzed. Among 149,082 (99.6%) reported cases for which age was known, 2,572 (1.7%) were among children aged <18 years. Data were available for a small proportion of patients on many important variables, including symptoms (9.4%), underlying conditions (13%), and hospitalization status (33%). Among those with available information, 73% of pediatric patients had symptoms of fever, cough, or shortness of breath compared with 93% of adults aged 18-64 years during the same period; 5.7% of all pediatric patients, or 20% of those for whom hospitalization status was known, were hospitalized, lower than the percentages hospitalized among all adults aged 18-64 years (10%) or those with known hospitalization status (33%). Three deaths were reported among the pediatric cases included in this analysis. These data support previous findings that children with COVID-19 might not have reported fever or cough as often as do adults (4). Whereas most COVID-19 cases in children are not severe, serious COVID-19 illness resulting in hospitalization still occurs in this age group. Social distancing and everyday preventive behaviors remain important for all age groups as patients with less serious illness and those without symptoms likely play an important role in disease transmission (6,7).","MMWR Morb Mortal Wkly Rep","32271728"],"abstract":["As of April 2, 2020, the coronavirus disease 2019 (COVID-19) pandemic has resulted in >890,000 cases and >45,000 deaths worldwide, including 239,279 cases and 5,443 deaths in the United States (1,2). In the United States, 22% of the population is made up of infants, children, and adolescents aged <18 years (children) (3). Data from China suggest that pediatric COVID-19 cases might be less severe than cases in adults and that children might experience different symptoms than do adults (4,5); however, disease characteristics among pediatric patients in the United States have not been described. Data from 149,760 laboratory-confirmed COVID-19 cases in the United States occurring during February 12-April 2, 2020 were analyzed. Among 149,082 (99.6%) reported cases for which age was known, 2,572 (1.7%) were among children aged <18 years. Data were available for a small proportion of patients on many important variables, including symptoms (9.4%), underlying conditions (13%), and hospitalization status (33%). Among those with available information, 73% of pediatric patients had symptoms of fever, cough, or shortness of breath compared with 93% of adults aged 18-64 years during the same period; 5.7% of all pediatric patients, or 20% of those for whom hospitalization status was known, were hospitalized, lower than the percentages hospitalized among all adults aged 18-64 years (10%) or those with known hospitalization status (33%). Three deaths were reported among the pediatric cases included in this analysis. These data support previous findings that children with COVID-19 might not have reported fever or cough as often as do adults (4). Whereas most COVID-19 cases in children are not severe, serious COVID-19 illness resulting in hospitalization still occurs in this age group. Social distancing and everyday preventive behaviors remain important for all age groups as patients with less serious illness and those without symptoms likely play an important role in disease transmission (6,7)."],"journal":"MMWR Morb Mortal Wkly Rep","date":"2020-04-10T11:00:00Z","year":2020,"_id":"32271728","week":"202015|Apr 06 - Apr 12","doi":"10.15585/mmwr.mm6914e4","source":"PubMed","locations":["China","United States"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Diagnosis","Prevention"],"weight":1,"_version_":1663620083120865280,"score":216.84169},{"pmid":32134205,"title":"Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.","text":["Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults.","PURPOSE: To discuss the different characteristics of clinical, laboratory, and chest computed tomography (CT) in pediatric patients from adults with 2019 novel coronavirus (COVID-19) infection. METHODS: The clinical, laboratory, and chest CT features of 20 pediatric inpatients with COVID-19 infection confirmed by pharyngeal swab COVID-19 nucleic acid test were retrospectively analyzed during 23 January and 8 February 2020. The clinical and laboratory information was obtained from inpatient records. All the patients were undergone chest CT in our hospital. RESULTS: Thirteen pediatric patients (13/20, 65%) had an identified history of close contact with COVID-19 diagnosed family members. Fever (12/20, 60%) and cough (13/20, 65%) were the most common symptoms. For laboratory findings, procalcitonin elevation (16/20, 80%) should be pay attention to, which is not common in adults. Coinfection (8/20, 40%) is common in pediatric patients. A total of 6 patients presented with unilateral pulmonary lesions (6/20, 30%), 10 with bilateral pulmonary lesions (10/20, 50%), and 4 cases showed no abnormality on chest CT (4/20, 20%). Consolidation with surrounding halo sign was observed in 10 patients (10/20, 50%), ground-glass opacities were observed in 12 patients (12/20, 60%), fine mesh shadow was observed in 4 patients (4/20, 20%), and tiny nodules were observed in 3 patients (3/20, 15%). CONCLUSION: Procalcitonin elevation and consolidation with surrounding halo signs were common in pediatric patients which were different from adults. It is suggested that underlying coinfection may be more common in pediatrics, and the consolidation with surrounding halo sign which is considered as a typical sign in pediatric patients.","Pediatr Pulmonol","Xia, Wei","Shao, Jianbo","Guo, Yu","Peng, Xuehua","Li, Zhen","Hu, Daoyu","32134205"],"abstract":["PURPOSE: To discuss the different characteristics of clinical, laboratory, and chest computed tomography (CT) in pediatric patients from adults with 2019 novel coronavirus (COVID-19) infection. METHODS: The clinical, laboratory, and chest CT features of 20 pediatric inpatients with COVID-19 infection confirmed by pharyngeal swab COVID-19 nucleic acid test were retrospectively analyzed during 23 January and 8 February 2020. The clinical and laboratory information was obtained from inpatient records. All the patients were undergone chest CT in our hospital. RESULTS: Thirteen pediatric patients (13/20, 65%) had an identified history of close contact with COVID-19 diagnosed family members. Fever (12/20, 60%) and cough (13/20, 65%) were the most common symptoms. For laboratory findings, procalcitonin elevation (16/20, 80%) should be pay attention to, which is not common in adults. Coinfection (8/20, 40%) is common in pediatric patients. A total of 6 patients presented with unilateral pulmonary lesions (6/20, 30%), 10 with bilateral pulmonary lesions (10/20, 50%), and 4 cases showed no abnormality on chest CT (4/20, 20%). Consolidation with surrounding halo sign was observed in 10 patients (10/20, 50%), ground-glass opacities were observed in 12 patients (12/20, 60%), fine mesh shadow was observed in 4 patients (4/20, 20%), and tiny nodules were observed in 3 patients (3/20, 15%). CONCLUSION: Procalcitonin elevation and consolidation with surrounding halo signs were common in pediatric patients which were different from adults. It is suggested that underlying coinfection may be more common in pediatrics, and the consolidation with surrounding halo sign which is considered as a typical sign in pediatric patients."],"journal":"Pediatr Pulmonol","authors":["Xia, Wei","Shao, Jianbo","Guo, Yu","Peng, Xuehua","Li, Zhen","Hu, Daoyu"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32134205","week":"202010|Mar 02 - Mar 08","doi":"10.1002/ppul.24718","keywords":["COVID-19","child","clinical features","infection","tomography"],"source":"PubMed","topics":["Transmission","Diagnosis"],"weight":1,"_version_":1663352134218809344,"score":213.2719}]}